Doxazosin Tablets — Class III drug recall D-0306-2026
Ongoing recall by Unichem Pharmaceuticals USA Inc., reported 2026-02-18, distributed nationwide. Tablets/Capsules Imprinted with Wrong ID
| Recall number | D-0306-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Unichem Pharmaceuticals USA Inc., East Brunswick, NJ, United States |
| Recall initiated | 2026-01-21 |
| Classified | 2026-02-11 |
| Reported by FDA | 2026-02-18 |
| Distributed | Nationwide (US) |
| Quantity | 60,000 tablets |
| NDC | 29300-0351, 29300-0351-01, 29300-0351-10, 29300-0351-13, 29300-0352, 29300-0352-01, 29300-0352-10, 29300-0352-13, 29300-0353, 29300-0353-01, 29300-0353-10, 29300-0353-13, 29300-0354, 29300-0354-01, 29300-0354-10, 29300-0354-13 |
| Lot numbers | GDSH25006 |
| Expiration dates | 2027-08 |
Product
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Reason for recall
Tablets/Capsules Imprinted with Wrong ID
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0306-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.